A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Generally, fighting cancer is about delivering a relentless attack on the spreading disease, but a new approach explores the ...

ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...

In the realm of cancer biology, the intersection of aging and cancer presents unique challenges, characterized by tumor ...

The field of immunotherapy has transformed the landscape of cancer treatment, particularly with solid tumors, introducing newer modalities that promise more ...